Nitric oxide (NO) is a short-lived, free radical gas that accounts for the biologic properties of endothelium-derive relaxing factor (EDRF). My previous work focused on the physiological role of NO in the regulation of cardiovascular homeostasis. However, a deeper understanding of the role of NO in cardiovascular disease requires investigation of the pathways of NO synthesis within the vasculature. This proposal investigates an important molecular pathway of NO gene regulation in vascular smooth muscle cells. Nitric oxide (NO) is a potent vasodilator that contributes to the regulation of vascular tone. NO is synthesized from L-arginine by nitric oxide synthase (NOS). Two general classes of NOS have been identified: constitutive isozymes (neuronal (nc)NOS and endothelial (ec)NOS) that are present in tissues under basal conditions, and an inducible isozyme (iNOS) that requires cytokine or endotoxin activation for expression. We have demonstrated that iNOS mRNA levels are increased after cytokine stimulation in vascular smooth muscle cells. This upregulation of iNOS is mediated at the transcriptional level., and transforming growth factor (TGF)-beta1 but not dexamethasone downregulates iNOS mRNA after its induction by cytokines. The broad objectives of this proposal are to evaluate the regulation of smooth muscle cell iNOS by interleukin(IL)-1beta stimulation in cell culture and to investigate the mechanism(s) by which TGF-beta1 downregulates the vascular iNOS response to IL-1beta. Since the rate of gene transcription is regulated by the interaction of specific DNA sequences (cis-acting elements) and their cognate binding proteins (trans- acting factors), we plan to identify and characterize the cis-acting elements and trans-acting factors important in mediating IL-1beta induction of the iNOS gene in vascular smooth muscle cells. These specific elements may provide a target for the inhibition of the iNOS gene after it has been stimulated by cytokines. The Cardiovascular Biology Laboratory of the Harvard School of Public Health will serve as the site for the studies described in this proposal. The Laboratory encompasses 12,000 square feet and is equipped with instruments designed for research in cellular and molecular biology, and protein chemistry.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL003194-02
Application #
2332427
Study Section
Research Training Review Committee (RTR)
Project Start
1996-02-01
Project End
2000-01-31
Budget Start
1997-02-01
Budget End
1998-01-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Maemura, K; Layne, M D; Watanabe, M et al. (2001) Molecular mechanisms of morning onset of myocardial infarction. Ann N Y Acad Sci 947:398-402
Wiesel, P; Foster, L C; Pellacani, A et al. (2000) Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators. J Biol Chem 275:24840-6
Foster, L C; Wiesel, P; Huggins, G S et al. (2000) Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells. FASEB J 14:368-78
Christou, H; Morita, T; Hsieh, C M et al. (2000) Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86:1224-9
Werner, F; Jain, M K; Feinberg, M W et al. (2000) Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem 275:36653-8
Pellacani, A; Chin, M T; Wiesel, P et al. (1999) Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase. J Biol Chem 274:1525-32
Perrella, M A; Pellacani, A; Wiesel, P et al. (1999) High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer. J Biol Chem 274:9045-52
Chin, M T; Pellacani, A; Hsieh, C M et al. (1999) Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro. J Mol Cell Cardiol 31:2199-205
Hsieh, C M; Yet, S F; Layne, M D et al. (1999) Genomic cloning and promoter analysis of aortic preferentially expressed gene-1. Identification of a vascular smooth muscle-specific promoter mediated by an E box motif. J Biol Chem 274:14344-51
Sibinga, N E; Wang, H; Perrella, M A et al. (1999) Interferon-gamma-mediated inhibition of cyclin A gene transcription is independent of individual cis-acting elements in the cyclin A promoter. J Biol Chem 274:12139-46

Showing the most recent 10 out of 24 publications